Andrew George | Academic Influence

Andrew George 's AcademicInfluence.com Rankings

Andrew George

Biology

#14510

World Rank

#18277

Historical Rank

Immunology

#1014

World Rank

#1039

Historical Rank

biology Degrees

Download Badge

Biology

Andrew George 's Degrees

Bachelors Biology University of Oxford
PhD Immunology University of Oxford

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2026

Why Is Andrew George Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Andrew John Timothy George , is Deputy Vice-Chancellor at Brunel University London and Professor of Immunology. Education George was educated at Clifton College, Bristol. He studied Natural Sciences at Trinity College, Cambridge , before going to the Tenovus Laboratories, Southampton University, where he undertook his PhD under the supervision of Freda Stevenson .

(See a Problem?)

Andrew George 's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The safety and side effects of monoclonal antibodies (2010) (811)
Antibody engineering: comparison of bacterial, yeast, insect and mammalian expression systems. (1998) (261)
Lipid-mediated enhancement of transfection by a nonviral integrin-targeting vector. (1998) (192)
Function of indoleamine 2,3‐dioxygenase in corneal allograft rejection and prolongation of allograft survival by over‐expression (2006) (181)
Inhibition of NF-κB and Oxidative Pathways in Human Dendritic Cells by Antioxidative Vitamins Generates Regulatory T Cells1 (2005) (178)
Goodpasture's disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques. (2002) (160)
Cytokines, chaos, and complexity. (1999) (158)
Anti-idiotypic mechanisms involved in suppression of a mouse B cell lymphoma, BCL1. (1987) (149)
Modulation of human dendritic-cell function following transduction with viral vectors: implications for gene therapy. (2005) (146)
Ischemia-Reperfusion Injury Reduces Long Term Renal Graft Survival: Mechanism and Beyond (2018) (145)
Activated polyamidoamine dendrimers, a non-viral vector for gene transfer to the corneal endothelium (1999) (144)
Corneal Transplantation: The Forgotten Graft (2004) (139)
Idiotypic vaccination as a treatment for a B cell lymphoma. (1988) (132)
Gene delivery by dendrimers operates via a cholesterol dependent pathway. (2004) (132)
Inflammatory cytokines induce apoptosis of corneal endothelium through nitric oxide. (2004) (122)
Adenovirus-mediated gene delivery to the corneal endothelium. (1996) (114)
T‐lymphocyte invasiveness: control by voltage‐gated Na+ channel activity (2004) (110)
Role of Toll-like receptor-4 in renal graft ischemia-reperfusion injury. (2014) (104)
Inhibition of NF-kappa B and oxidative pathways in human dendritic cells by antioxidative vitamins generates regulatory T cells. (2005) (97)
Cytokine and chemokine expression kinetics after corneal transplantation. (2000) (93)
Phenotypic and functional differences between human saphenous vein (HSVEC) and umbilical vein (HUVEC) endothelial cells. (2004) (87)
Effect of administration of CTLA4-Ig as protein or cDNA on corneal allograft survival. (2002) (86)
Measurement of kinetic binding constants of a panel of anti-saporin antibodies using a resonant mirror biosensor. (1995) (83)
Detection of vascular expression of E-selectin in vivo with MR imaging. (2006) (82)
The glycophosphatidylinositol anchor affects the conformation of Thy-1 protein. (1995) (79)
Characterization of a new monoclonal anti-Fc gamma RII antibody, AT10, and its incorporation into a bispecific F(ab')2 derivative for recruitment of cytotoxic effectors. (1991) (74)
Identification of synovium-specific homing peptides by in vivo phage display selection. (2002) (73)
Cooperative enhancement of specificity in a lattice of T cell receptors (2001) (71)
3-hydroxykynurenine suppresses CD4+ T-cell proliferation, induces T-regulatory-cell development, and prolongs corneal allograft survival. (2011) (71)
Receptor editing during affinity maturation. (1999) (70)
Oscillations in the immune system (2007) (69)
Mammalian expression and secretion of functional single-chain Fv molecules. (1994) (68)
Immunolipoplexes: an efficient, nonviral alternative for transfection of human dendritic cells with potential for clinical vaccination. (2005) (68)
Source of oncofetal ED-B-containing fibronectin: implications of production by both tumor and endothelial cells. (2000) (67)
Engineered antibodies take center stage. (2001) (66)
Creation of tolerogenic human dendritic cells via intracellular CTLA4: a novel strategy with potential in clinical immunosuppression. (2005) (65)
Importance of the linker in expression of single-chain Fv antibody fragments: optimisation of peptide sequence using phage display technology. (1997) (64)
Aspirin‐Treated Human DCs Up‐Regulate ILT‐3 and Induce Hyporesponsiveness and Regulatory Activity in Responder T Cells (2006) (62)
Radiometal labeling of recombinant proteins by a genetically engineered minimal chelation site: technetium-99m coordination by single-chain Fv antibody fusion proteins through a C-terminal cysteinyl peptide. (1995) (61)
TNF receptor secretion after ex vivo adenoviral gene transfer to cornea and effect on in vivo graft survival. (2001) (60)
Differential effects of costimulatory pathway modulation on corneal allograft survival. (2006) (57)
Prospects for the treatment of B cell tumors using idiotypic vaccination. (1989) (56)
Gene delivery by dendrimers operates via different pathways in different cells, but is enhanced by the presence of caveolin. (2006) (56)
Redirection of T cell-mediated cytotoxicity by a recombinant single-chain Fv molecule. (1994) (56)
In vivo selection of sFv from phage display libraries. (2000) (56)
Anti‐neutrophil cytoplasmic antibodies (ANCA) from patients with systemic vasculitis recognize restricted epitopes of proteinase 3 involving the catalytic site (2001) (54)
Adeno-associated and Herpes Simplex Viruses as Vectors for Gene Transfer to the Corneal Endothelium (2000) (53)
Selection of antibodies to cell surface determinants on mouse thymic epithelial cells using a phage display library (1997) (52)
Anti-idiotypic therapy of leukemias and lymphomas. (1990) (52)
Recognition of a B cell lymphoma by anti-idiotypic T cells. (1990) (51)
Xenon Treatment Protects Against Cold Ischemia Associated Delayed Graft Function and Prolongs Graft Survival in Rats (2013) (50)
TRANSFERRIN RECEPTOR-MEDIATED GENE TRANSFER TO THE CORNEAL ENDOTHELIUM1 (2001) (49)
Understanding specificity and sensitivity of T-cell recognition. (2005) (49)
Gene delivery to the corneal endothelium. (2000) (48)
Idiotypic vaccination against B-cell lymphoma leads to dormant tumour. (1991) (48)
An Approach to Modelling in Immunology (2001) (47)
Comparison of HIV-1 and EIAV-based lentiviral vectors in corneal transduction. (2005) (47)
Aspirin modified dendritic cells are potent inducers of allo-specific regulatory T-cells. (2006) (47)
Local bioactive tumour necrosis factor (TNF) in corneal allotransplantation (2000) (47)
Role of Alloantibodies in the Pathogenesis of Graft Arteriosclerosis in Cardiac Transplantation (2006) (46)
Reconstruction of cell population dynamics using CFSE (2007) (45)
Targeting gene delivery to activated vascular endothelium using anti E/P-Selectin antibody linked to PAMAM dendrimers. (2009) (45)
A phase I trial of idiotypic vaccination with HMFG1 in ovarian cancer (2004) (44)
Single-chain Fv radioimmunotargeting. (1996) (44)
Lipoadenofection-mediated gene delivery to the corneal endothelium: prospects for modulating graft rejection. (1998) (42)
A bacterially expressed single-chain Fv construct from the 2B4 T-cell receptor. (1993) (41)
Gene transfer to ex vivo stored corneas. (1997) (40)
Synthesis and in vitro evaluation of [18F]fluoroethyl triazole labelled [Tyr3]octreotate analogues using click chemistry. (2011) (39)
A kinetic differentiation model for the action of altered TCR ligands. (1999) (38)
Targeting Somatostatin Receptors: Preclinical Evaluation of Novel 18F-Fluoroethyltriazole-Tyr3-Octreotate Analogs for PET (2011) (38)
Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection. (2003) (38)
The gp200‐MR6 molecule which is functionally associated with the IL‐4 receptor modulates B cell phenotype and is a novel member of the human macrophage mannose receptor family (1998) (37)
Feedback control of T–cell receptor activation (2004) (37)
A rapid method for labelling CD4+ T cells with ultrasmall paramagnetic iron oxide nanoparticles for magnetic resonance imaging that preserves proliferative, regulatory and migratory behaviour in vitro. (2006) (37)
Induction of tumor-specific T-cell responses by vaccination with tumor lysate-loaded dendritic cells in colorectal cancer patients with carcinoembryonic-antigen positive tumors (2007) (36)
T cell sensitivity and specificity - kinetic proofreading revisited (2003) (35)
Indium-111 labelled lymphocytes: isotope distribution and cell division (1997) (35)
Expression of hirudin fusion proteins in mammalian cells: a strategy for prevention of intravascular thrombosis. (1998) (33)
Delivery of the ribosome-inactivating protein, gelonin, to lymphoma cells via CD22 and CD38 using bispecific antibodies. (1995) (33)
Early treatment with xenon protects against the cold ischemia associated with chronic allograft nephropathy in rats. (2014) (32)
Xenon treatment attenuates early renal allograft injury associated with prolonged hypothermic storage in rats (2013) (30)
Effect of Vectors on Human Endothelial Cell Signal Transduction: Implications for Cardiovascular Gene Therapy (2006) (30)
Induction of tumor-specific T-cell responses by vaccination with tumor lysate-loaded dendritic cells in colorectal cancer patients with carcinoembryonic-antigen positive tumors (2007) (29)
Immune modulation in corneal transplantation. (2008) (29)
Effect of vectors on human endothelial cell signal transduction: implications for cardiovascular gene therapy. (2006) (28)
Redesigned anti-human placental alkaline phosphatase single-chain Fv: soluble expression, characterization and in vivo tumour targeting. (1997) (27)
Delivery of oligodeoxynucleotides into human saphenous veins and the adjunct effect of ultrasound and microbubbles. (2005) (27)
Analysis of soluble HLA class II antigenic material in patients with immunological diseases using monoclonal antibodies. (1986) (26)
Xenon Treatment Protects against Remote Lung Injury after Kidney Transplantation in Rats (2015) (26)
Antibody engineering. (1994) (26)
Idiotype vaccination leads to the emergence of a stable surface Ig-negative variant of the mouse lymphoma BCL1, with different growth characteristics. (1988) (26)
Tolerant T cells display impaired trafficking ability (2005) (26)
Use of 2-[18F]fluoro-2-deoxyglucose as a potential agent in the prediction of graft rejection by positron emission tomography. (1998) (25)
Monoclonal antibodies raised against the idiotype of the murine B cell lymphoma, BCL1 act primarily with heavy chain determinants. (1991) (25)
Isolating ligands specific for human vasculature using in vivo phage selection. (2003) (25)
A CIITA‐independent pathway that promotes expression of endogenous rather than exogenous peptides in immune‐privileged sites (2004) (24)
Arginine depletion as a mechanism for the immune privilege of corneal allografts (2011) (23)
Dendritic cell modification as a route to inhibiting corneal graft rejection by the indirect pathway of allorecognition (2012) (23)
Applications of monoclonal antibodies in clinical oncology. (1994) (23)
Distribution of integrins αvβ5, αvβ3 and αv in normal human cornea: Possible implications in clinical and therapeutic adenoviral infection (1998) (22)
Oligopeptide-mediated gene transfer into mouse corneal endothelial cells: expression, design optimization, uptake mechanism and nuclear localization (2009) (22)
Tolerance mechanisms and recent progress. (2004) (22)
Targeting of anti-tumor responses with bispecific antibodies. (1992) (20)
A novel strategy for preserving renal grafts in an ex vivo setting: potential for enhancing the marginal donor pool (2013) (20)
Expression of the Chemokine Antagonist vMIP II Using a Non-Viral Vector Can Prolong Corneal Allograft Survival (2008) (19)
Activated T cells modulate immunosuppression by embryonic-and bone marrow-derived mesenchymal stromal cells through a feedback mechanism. (2012) (19)
Intra‐thecal treatment of leptomeningeal lymphoma with immunotoxin (1991) (19)
Regulation of Rat and Human T-Cell Immune Response by Pharmacologically Modified Dendritic Cells (2009) (18)
Absence of immunogenicity of diaspirin cross-linked hemoglobin in humans. (1998) (18)
Characterization of autoantibodies from patients with Goodpasture’s disease using a resonant mirror biosensor (2002) (18)
Construction, expression and characterisation of a single chain anti-tumour antibody (scFv)-IL-2 fusion protein. (1995) (17)
Epitope analysis of the Goodpasture antigen using a resonant mirror biosensor (1996) (17)
Anti-Idiotypic Therapy of Leukemias and Lymphomas (Part 1 of 2) (1990) (17)
Demonstration of IgM antibodies of high affinity within the anti-Galalpha1-3Gal antibody repertoire. (1998) (17)
Diagnostic and Therapeutic Antibodies (2000) (16)
Surface-bound cytokines--a possible effector-mechanism in bacterial immunity. (1994) (15)
A sensitive fluorometric assay for determining hydrogen peroxide-mediated sublethal and lethal endothelial cell injury. (1998) (15)
Strategies to improve non-viral vectors – potential applications in clinical transplantation (2006) (14)
Upregulation of chemokine expression in murine cornea due to mechanical trauma or endotoxin (2007) (13)
Inhibition of NF- B and Oxidative Pathways in Human Dendritic Cells by Antioxidative Vitamins Generates Regulatory T Cells (2005) (13)
Development of a novel recombinant biotherapeutic with applications in targeted therapy of human arthritis. (2011) (13)
Smooth muscle cell proliferation but not neointimal formation is dependent on alloantibody in a murine model of intimal hyperplasia (2006) (12)
Modulation of hydrogen peroxide induced injury to corneal endothelium by virus mediated catalase gene transfer (2002) (12)
The evolving role of gene‐based treatment in surgery (2005) (11)
Modulation of Costimulation by CD 28 and CD 154 Alters the Kinetics and Cellular Characteristics of Corneal Allograft Rejection (2003) (10)
Prevention of Hydrogen Peroxide and Cisplatin Induced Apoptosis by Intracellular Catalase Overexpression (2000) (10)
The impact of multiple T cell-APC encounters and the role of anergy (2005) (10)
Is the number of genes we possess limited by the presence of an adaptive immune system? (2002) (10)
Kinetics of biomolecular interactions (1997) (9)
Knockdown of mouse VCAM-1 by vector-based siRNA. (2006) (8)
Imaging Molecular and Cellular Events in Transplantation (2006) (8)
Changing Viral Tropism Using Immunoliposomes Alters the Stability of Gene Expression: Implications for Viral Vector Design (2007) (7)
Inhibition of expression of the Galα1-3Gal epitope on porcine cells using an intracellular single-chain antibody directed against α1,3Galactosyltransferase (1999) (7)
Inhibition of NFkB and oxidative pathways in human dendritic cells by anti-oxidative vitamins generates regulatory T cells (2005) (7)
Targeted cytokine production. (1992) (6)
Section Review Biologicals & Immunologicals: Advances in antibody engineering (1996) (6)
Suppression of the allogeneic response by the anti‐allergy drug N‐(3,4‐dimethoxycinnamonyl) anthranilic acid results from T‐cell cycle arrest (2013) (6)
Distribution of integrins alpha v beta 5, alpha v beta 3 and alpha v in normal human cornea: possible implications in clinical and therapeutic adenoviral infection. (1998) (6)
Exploring and exploiting the antibody and Ig superfamily combining sites (1996) (5)
The kinetics of MHC class I and class II expression in rat renal allografts. (1996) (5)
Targeted Cellular Cytotoxicity (1993) (5)
Characterisation of a light chain loss variant of the BCL1 lymphoma. (1991) (5)
Peptide-mediated non-viral gene transfer for transplantation. (2000) (4)
Anti-LFA-1 monotherapy prevents neointimal formation in a murine model of transplant intimal hyperplasia. (2007) (4)
Regulation of indoleamine 2,3-dioxygenase in primary human saphenous vein endothelial cells (2015) (4)
Measurement of the Kinetics of Biomolecular Interactions Using the IAsys Resonant Mirror Biosensor (1999) (4)
The antibody molecule. (2000) (3)
Inhibition of expression of the Galalpha1-3Gal epitope on porcine cells using an intracellular single-chain antibody directed against alpha1,3galactosyltransferase. (1999) (2)
Use of biosensors to measure the kinetics of antibody-antigen interactions. (2000) (2)
SARS-CoV-2: Pathogenic Mechanisms and Host Immune Response. (2021) (2)
Transfection of indoleamine 2,3 dioxygenase in primary endothelial cells. (2010) (2)
Enhancing SIRT1 Gene Expression Using Small Activating RNAs: A Novel Approach for Reversing Metabolic Syndrome. (2022) (2)
Peptides as Promising Non-Viral Vectors for Gene Therapy (2011) (2)
Cytotoxic Killing and Immune Evasion by Repair (2007) (2)
Ethics, virtues and xenotransplantation. (2022) (1)
Expression and Function of Indoleamine 2,3–Dioxygenase in Murine Cornea (2005) (1)
Prevention of co-stimulation molecule expression using intracellular CTLA4: A novel strategy for induction of T cell anergy (2003) (1)
CD28 and CD154 Pathway Costimulatory Blockade Prolongs Corneal Allograft Survival (2002) (1)
Anti-Idiotypic Therapy of Leukemias and Lymphomas (Part 2 of 2) (1990) (1)
Gene therapy for clinical transplantation: where do we stand in 2006? (2006) (1)
Animal biotechnology in medicine (1998) (1)
with potential in clinical immunosuppression Creation of tolerogenic human DC via intracellular CTLA4: a novel strategy (2012) (1)
395. Role of Caveoli on Membrane Raft in the Internalization of Non-Viral Vectors (2006) (0)
anticoagulants hybrid proteins linked to cell membranes. (1998) (0)
Therapeutic monoclonals. (1995) (0)
1042. Creation of Tolerogenic Dendritic Cells by Non Viral Gene Transfer with Immunoliposomes (2005) (0)
Book Review: Renal Cell Carcinoma (2000) (0)
464. Use of Equine Infectious Anaemia Virus (EIAV) To Mediate Indoleamine 2,3-dioxygenase Gene Transfer to Murine Corneal Allograft Transplantation Model Results in Prolongation of Allograft Survival In Vivo with Little Immunogenicity (2006) (0)
Perfecting single chain Fv imaging agents (1996) (0)
Humoral effector mechanisms in the immunity to cancer. (1990) (0)
Anti-idiotypic immunity and tumour dormancy in a mouse B-cell lymphoma (1987) (0)
196. Genetic Manipulation of Dendritic Cells through the Use of Immunolipoplexes To Induce T Cell-Specific Tolerance In Vivo (2006) (0)
Xenograft rejection suppression. (1999) (0)
48 Targeting melanoma using a single-chain - IL-2 fusion protein (1997) (0)
550. Delivery of Oligodeoxynucleotides into Human Saphenous Veins and the Adjunct Effect of Ultrasound and Microbubbles (2006) (0)
REVERSAL OF COSTIMULATION BY CELL SURFACE EXPRESSION OF AN ANTI‐CD152 SINGLE CHAIN ANTIBODY.: Abstract# 887 Poster Board #‐Session: P144‐III (2000) (0)
773. Role of Lipid-Rafts in the Binding and Internalization of Dendriplexes and Lipoplexes (2005) (0)
PREVENTION OF HYDROGEN PEROXIDE- AND CISPLATIN-INDUCED APOPTOSIS BY CATALASE OVEREXPRESSION (1996) (0)
877. Differential Expression of Indoleamine 2,3-dioxygenase (IDO) by Endothelial Cells and Its Overexpression by Gene Transfer: Implications for Cardiovascular Biology (2006) (0)
Transplantation Society--XXth International Congress. 5-10 September 2004, Vienna, Austria. (2004) (0)
981. Modulation of Human Dendritic Cell Function Following Viral Vectors: Implications for Gene Therapy in Vaccination (2005) (0)
Redirection of cellular cytotoxicity (1995) (0)
Novel Contrast Agents for Magnetic Resonance Imaging of Inflammation (2002) (0)
Application of Phage Display Technology to Endothelial Cell Immunobiology (2002) (0)
Dendritic cells in cancer immunotherapy. 10 January 2005, London, UK. (2005) (0)
Regulation of the B cell response by cytokines (1991) (0)
Modulation of the immune response by targeting endothelial cells (2007) (0)
The Use of Adenoviral Vectors to Genetically Modify Donor Cornea Prior to Transplantation (1996) (0)
World Transplant Congress 2006 LEUKOCYTE TRAFFICKING I: CYTOKINES, CHEMOKINES AND ADHESION MOLECULES analysed at rest or after cytokine treatment by PE-labelled, commercially available, anti-chemokine receptor antibodies against CCR1, CCR2, CCR5, CCR7 and CXCR3 with flow cytometry on a BD FACScalibu (2006) (0)
Vitamins Generates Regulatory T Cells in Human Dendritic Cells by Antioxidative B and Oxidative Pathways k Inhibition of NF-Foxwell, (2005) (0)
INTRABODY MEDIATED INHIBITION OF VCAM EXPRESSION ON PORCINE ENDOTHELIAL CELLS AS A STRATEGY TO PREVENT RECRUITMENT OF HUMAN MONONUCLEAR LEUKOCYTES IN XENOTRANSPLANTATION.: Abstract# 1023 (2000) (0)
Gene Transfer to Human Corneal Endothelium using Equine Infectious Anemia Virus (2003) (0)
Biologicals & Immunologicals Kinetics of biomolecular interactions (1997) (0)
INTRACELLULAR RETENTION OF CD80/86 BY DENDRITIC CELLS, UNLIKE TRYPTOPHAN CATABOLISM, AS A MECHANISM TO INDUCE REGULATORY T CELL MEDIATED DONOR-SPECIFIC TOLERANCE: 2222 (2008) (0)
Xenotransplantation: Will Pigs Fly? (2002) (0)
CYTOKINE AND CHEMOKINE EXPRESSION KINETICS AFTER CORNEAL TRANSPLANTATION1 (2000) (0)
Involvement of innate and induced anti-idiotypic mechanisms in suppression of B cell tumors. (1987) (0)
Prolongation of Mouse Corneal Allograft Survival Following Systemic ‘Tranilast’ Administration (2011) (0)
PROLONGATION OF CORNEAL GRAFT SURVIVAL FOLLOWING ADMINISTRATION OF 3-HYDROXYKYNURENINE.: 28 (2008) (0)
Novel triblock oligopeptides as efficient nonviral vectors: characterisation and further insights. (2010) (0)
CREATION OF TOLEROGENIC ANTIGEN PRESENTING CELLS VIA INTRACELLULAR CTLA4: A NOVEL STRATEGY WITH POTENTIAL CLINICAL UTILITY IN TRANSPLANTATION. (2004) (0)
Macromolecular synthetic biomaterials for delivery of therapeutics. (2010) (0)
Prolongation of Mouse Corneal Allograft Survival Following Systemic and Topical 3-Hydroxykynurenine (3HK) Administration (2010) (0)
Creation of tolerogenic human dendritic cells via intracellular CTLA4 : a novel stategy with potential in clinical immunosuppression. Commentary (2005) (0)
Intracellular retention of CD80/86 by dendritic cells, unlike tryptophan catabolism, as a mechanism to induce regulatory T cell-mediated donor-specific tolerance. (2008) (0)
SIGNIFICANCE OF PROSTAGLANDIN E2 RECEPTORS AND THERAPEUTIC EFFICACY OF HIGHLY SELECTIVE RECEPTOR AGONIST IN ALLOIMMUNE RESOPNSE IN VIVO (2006) (0)
Biological Insights into the Complex Nature of Vitamin E (2003) (0)
Cytokine Therapy (2021) (0)
Selection of homing peptides specific for human synovium transplanted into SCID mice from phage display in vivo (2002) (0)
Costimulatory Molecules on Murine Endothelium; Implications for Corneal Graft Rejection (2005) (0)
The Humoral Immune Response to Monoclonal Antibody Therapy for Ovarian Cancer (1998) (0)
Monoclonal Antibody Therapy (2010) (0)
Book Review: Diagnostic and Therapeutic Antibodies (2000) (0)

This paper list is powered by the following services:

Other Resources About Andrew George

en.wikipedia.org

What Schools Are Affiliated With Andrew George ?

Andrew George is affiliated with the following schools: